Global Exoskeleton (Medical/Non-Medical) Market Analysis/Research Report 2023-2035: Strategic Partnerships and Collaborations, Patent Analysis, Blue Ocean Strategy, Competitive Analysis, Forecasts

DUBLIN, March 11, 2024 /PRNewswire/ -- The "Global Exoskeleton Market 2023-2035 by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users and Geography" report has been added to  ResearchAndMarkets.com's offering.

The Global Exoskeleton Market is estimated to be worth over USD 20 billion in 2035 and is expected to grow at compounded annual growth rate (CAGR) of 23.1% during the forecast period (2023-2035)

The primary objective of this market report is to conduct a comprehensive market forecast analysis, aiming to estimate both the current market size and the future opportunities for exoskeleton companies over the next decade. Through an in-depth examination of historical market data within the industry, we have sought to gain a profound understanding of the evolutionary market trends. 

Beyond the healthcare industry, exoskeleton technology is serving to augment the performance as well as prevent work-related accidents of workers employed in a wide range of industries, such as construction, logistics, vehicle factory, aircraft manufacture, shipyard, automotive / metal mechanics industry, foundry, aeronautics, maintenance, and other factory works. 

Despite their widespread benefits, several factors, including the cost barriers and lack of awareness limit the adoption of these devices amongst users. In order to ensure wider acceptance, exoskeleton companies are focusing their R&D efforts to lower the cost of exoskeleton, as well as integrating technologies such as cloud computing, deep learning, smart sensors and artificial intelligence in their exoskeleton portfolio.

As the exoskeleton technology advances and the cost of exoskeletons decreases, and the stakeholders recognize the positive return on investment (ROI) on exoskeleton products (owing to higher benefit-cost ratio), the adoption of this nascent exoskeleton technology across various industries is poised to grow, ultimately driving the growth of the global exoskeleton market during the forecast period.

The majority of the exoskeleton companies are headquartered in North America, followed by those based in Europe. Consequently, nearly 40% of the global market for exoskeletons is anticipated to be captured by exoskeleton companies based in North America, in 2035. According to data from the Centers for Disease Control and Prevention (CDC), it is estimated that approximately 61 million people in the United States live with various forms of impairment, and among these individuals, mobility disabilities constitute a significant portion, accounting for 13.7% of the disabled population.

As per the projections of the United States Census Bureau (USCB), the US population aged 65 and older is expected to more than double by the year 2050. This demographic shift has the potential to significantly increase the demand for medical exoskeletons throughout the nation. Further, the exoskeleton market in Asia-Pacific is expected to grow at a relatively high CAGR of ~30% during the forecast period (2023-2035).

Market Trends: Partnerships and Collaborations on the Rise for Medical Exoskeleton

In recent years, several partnerships have been inked by industry stakeholders, in order to consolidate their presence in this field. It is worth highlighting that nearly 60% of deals were forged in the last three years (since 2020). Interestingly, most of the agreements were distribution agreements (26%), followed by product / technology development agreements (15%).

In July 2023, Wandercraft entered into an agreement with Brazilian Health authority to provide its two Atalante X exoskeletons at Lucy Montoro, a Brazilian neurological rehabilitation institution to support patient rehabilitation and medical research. Further, in June 2023, Trexo Robotics entered into a commercialization agreement with Keystone Education Group to use their Trexo Robotic Gait Trainer exoskeleton for children with autism spectrum disorder.

 The report features detailed transcripts of interviews held with the following industry stakeholders:

• Co-Founder and Chief Executive Officer, Small Company, Spain
• Director of Business Planning and Development, Small Company, Japan
• Vice President of Sales and Marketing, Small Company, USA
• Marketing and Design Manager, Small Company, Canada
• Founder and Director, Small Company, India

Key Exoskeleton Companies Profiled

• Bionic Yantra
• CYBERDYNE
• Ekso Bionics
• ExoAtlet
• Fourier Intelligence
• Gloreha
• Guangzhou Yikang Medical Equipment
• Hexar Humancare
• Hocoma
• MediTouch
• Milebot Robotics
• Myomo
• Neofect
• NextStep Robotics
• Panasonic
• ReWalk Robotics
• Rex Bionics
• Roam Robotics
• Trexo Robotics
• Tyromotion
• U&O Technologies

Key Topics Covered:

1. PREFACE

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact/Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.3. Foreign Exchange Impact
3.2.4. Recession
3.2.5. Inflation

4. EXECUTIVE SUMMARY

5. INTRODUCTION
5.1. Chapter Overview
5.2. Overview of Exoskeleton
5.3. History of Exoskeleton
5.4. Classification of Exoskeleton
5.5. Applications of Exoskeleton
5.6. Features of Exoskeleton
5.7. Limitations of Exoskeleton
5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Exoskeleton: Overall Market Landscape
6.3. Medical Exoskeleton: Developer: Landscape

7. NON-MEDICAL EXOSKELETON: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Non-Medical Exoskeleton: Overall Market Landscape
7.3. Non-Medical Exoskeleton: Developer Landscape

8. MEDICAL EXOSKELETON: PRODUCT COMPETITVENESS ANALYSIS
8.1 Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Medical Exoskeleton: Product Competitiveness Analysis

9. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES
9.1. Chapter Overview
9.2. CYBERDYNE
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Product Portfolio
9.2.4 Recent Developments and Future Outlook
9.3. Ekso Bionics
9.4. ExoAtlet
9.5. Fourier Intelligence
9.6. Gloreha
9.7. Guangzhou Yikang
9.8. Hexar Humancare
9.9. Hocoma
9.10. Panasonic
9.11. Tyromotion

10. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES
10.1. Chapter Overview
10.2. Bionic Yantra
10.3. MediTouch
10.4. Milebot Robotics
10.5. Myomo
10.6. Neofect
10.7. NextStep Robotics
10.8. ReWalk Robotics
10.9. Rex Bionics
10.10. Roam Robotics
10.11. Trexo Robotics
10.12. U&O Technologies

11. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS
11.1. Chapter Overview
11.2. Partnership Models
11.3. Medical Exoskeleton: List of Partnerships and Collaborations

12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Exoskeleton: Patent Analysis
12.4. Exoskeleton: Patent Benchmarking
12.5. Leading Players by Number of Citations

13. BLUE OCEAN STRATEGY
13.1. Overview of Blue Ocean Strategy
13.1.1. Red Oceans
13.1.2. Blue Oceans
13.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
13.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
13.1.4.1. Strategy Canvas
13.1.4.2. Pioneer-Migrator-Settler (PMS) Map
13.1.4.3. Buyer Utility Map

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion

15. GLOBAL EXOSKELETON MARKET
15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Key Market Segmentations
15.5. Dynamic Dashboard

16. EXOSKELETON MARKET, BY BODY PART COVERED
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions

17. EXOSKELETON MARKET, BY MODE OF OPERATION
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions

18. EXOSKELETON MARKET, BY THEIR FORM
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions

19. EXOSKELETON MARKET, BY THEIR MOBILITY
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions

20. EXOSKELETON MARKET, BY END USERS
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions

21. EXOSKELETON MARKET, BY GEOGRAPHY
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions

For more information about this report visit https://www.researchandmarkets.com/r/40ef8e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]    

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716 

Logo:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg 

SOURCE Research and Markets